Amza Abdou
Biographic Data
| ID | 9801029 |
|---|---|
| NAME | Amza Abdou |
| GIVEN NAMES | Amza |
| FAMILY NAME | Abdou |
| SIGNATURE | ABDOU A |
| AFFILIATIONS | Programme Nationale de Santé Oculaire, Niamey, Niger |
| VERIFIED | No |
| TOTAL WORKS | 3 |
| TOTAL CITATIONS | 0 |
| AUTHOR COUNT | 3 |
| EDITOR COUNT | 0 |
| FIRST PUBLICATION YEAR | 2022 |
| LATEST PUBLICATION YEAR | 2025 |
| H-INDEX | 0 |
Seasonality of underweight among infants 1–11 months old in Niger
INTRODUCTION: Malnutrition is a risk factor for child mortality, with around 45% of deaths in children under 5 globally linked to malnutrition. Seasonality of malnutrition has important implications for the timing of child health programme activities, but evidence is mixed on the nature of such patterns. Moreover, the bulk of the existing evidence is focused on wasting and stunting in children 6-59 months, despite increasing evidence that younger…
Effect of biannual azithromycin on respiratory pathogens among symptomatic children
Introduction Biannual (ie, every 6 months) mass drug administration of azithromycin has reduced childhood mortality in Niger, but its effects on specific respiratory pathogens are not fully elucidated. Methods Across 2 years of the Macrolides Oraux pour Réduire les Décès avec un Oeil sur la Résistance (MORDOR) study in Niger, we evaluated 1468 nasopharyngeal swabs from children who presented for care with respiratory symptoms. Swabs were tested b…
Simplified dosing of oral azithromycin for children 1–11 months old in child survival programmes
BACKGROUND: To facilitate mass distribution of azithromycin, trachoma control programmes use height instead of weight to determine dose for children 6 months to 15 years old. WHO has recommended azithromycin distribution to children 1-11 months old to reduce mortality in high mortality settings under carefully monitored conditions. Weight was used to determine dose in children 1-5 months old in studies of azithromycin distribution for child survi…
No prominent works on this page.
Simplified dosing of oral azithromycin for children 1–11 months old in child survival programmes
BACKGROUND: To facilitate mass distribution of azithromycin, trachoma control programmes use height instead of weight to determine dose for children 6 months to 15 years old. WHO has recommended azithromycin distribution to children 1-11 months old to reduce mortality in high mortality settings under carefully monitored conditions. Weight was used to determine dose in children 1-5 months old in studies of azithromycin distribution for child survi…
Seasonality of underweight among infants 1–11 months old in Niger
INTRODUCTION: Malnutrition is a risk factor for child mortality, with around 45% of deaths in children under 5 globally linked to malnutrition. Seasonality of malnutrition has important implications for the timing of child health programme activities, but evidence is mixed on the nature of such patterns. Moreover, the bulk of the existing evidence is focused on wasting and stunting in children 6-59 months, despite increasing evidence that younger…
Effect of biannual azithromycin on respiratory pathogens among symptomatic children
Introduction Biannual (ie, every 6 months) mass drug administration of azithromycin has reduced childhood mortality in Niger, but its effects on specific respiratory pathogens are not fully elucidated. Methods Across 2 years of the Macrolides Oraux pour Réduire les Décès avec un Oeil sur la Résistance (MORDOR) study in Niger, we evaluated 1468 nasopharyngeal swabs from children who presented for care with respiratory symptoms. Swabs were tested b…
Internal Medicine (3 works) · Medicine (3 works) · Antibiotics (2 works) · Azithromycin (2 works) · Environmental health (2 works) · Pediatrics (2 works) · Pneumonia and Respiratory Infections (2 works) · Biology (1 works) · Birth, Development, and Health (1 works) · Body mass index (1 works)